These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 21590561)

  • 21. A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia.
    Chua GN; Hassali MA; Shafie AA; Awaisu A
    Health Policy; 2010 May; 95(2-3):229-35. PubMed ID: 20044165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Are medical students influenced by the promotion of the pharmaceutical industry?].
    Giustetto G
    Recenti Prog Med; 2014 Dec; 105(12):445-7. PubMed ID: 25533229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of tiered prescription copayments on the use of preferred brand medications.
    Rector TS; Finch MD; Danzon PM; Pauly MV; Manda BS
    Med Care; 2003 Mar; 41(3):398-406. PubMed ID: 12618643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Under the radar": nurse practitioner prescribers and pharmaceutical industry promotions.
    Ladd EC; Mahoney DF; Emani S
    Am J Manag Care; 2010 Dec; 16(12):e358-62. PubMed ID: 21291293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns and predictors of prescription medication use in the management of headache: findings from the 2000 Medical Expenditure Panel Survey.
    Devine JW; Farley JF; Hadsall RS
    Headache; 2005 Oct; 45(9):1171-80. PubMed ID: 16178947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of direct-to-consumer advertising of hydroxymethylglutaryl coenzyme a reductase inhibitors on attainment of LDL-C goals.
    Bradford WD; Kleit AN; Nietert PJ; Ornstein S
    Clin Ther; 2006 Dec; 28(12):2105-18; discussion 2104. PubMed ID: 17296467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Financial incentives and physicians' prescription decisions on the choice between brand-name and generic drugs: evidence from Taiwan.
    Liu YM; Yang YH; Hsieh CR
    J Health Econ; 2009 Mar; 28(2):341-9. PubMed ID: 19091433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of nonclinical factors on practice variations: the case of hysterectomies.
    Geller SE; Burns LR; Brailer DJ
    Health Serv Res; 1996 Feb; 30(6):729-50. PubMed ID: 8591927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Towards accurate prescribing analysis in general practice: accounting for the effects of practice demography.
    Sleator DJ
    Br J Gen Pract; 1993 Mar; 43(368):102-6. PubMed ID: 8323786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient awareness and concern regarding pharmaceutical manufacturer interactions with doctors.
    Edwards D; Ballantyne A
    Intern Med J; 2009 Mar; 39(3):191-6. PubMed ID: 19383067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of pharmaceutical marketing on prescription practices of physicians.
    Narendran R; Narendranathan M
    J Indian Med Assoc; 2013 Jan; 111(1):47-50. PubMed ID: 24000508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An evaluation of educational outreach to improve evidence-based prescribing in Medicaid: a cautionary tale.
    Zillich AJ; Ackermann RT; Stump TE; Ambuehl RJ; Downs SM; Holmes AM; Katz B; Inui TS
    J Eval Clin Pract; 2008 Oct; 14(5):854-60. PubMed ID: 19018918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Case selection for statins was similar in two Canadian provinces: BC and Ontario.
    Paterson JM; Carney G; Anderson GM; Bassett K; Naglie G; Laupacis A;
    J Clin Epidemiol; 2007 Jan; 60(1):73-8. PubMed ID: 17161757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generics: what's in a name?
    Keith LG; Oleszczuk JJ; Stika CS; Stine S
    Int J Fertil Womens Med; 1998; 43(3):139-49. PubMed ID: 9692536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of prescription practices and of the rational use of medicines in Niger].
    Mallet HP; Njikam A; Scouflaire SM
    Sante; 2001; 11(3):185-93. PubMed ID: 11641083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physician acquiescence to patient demands for brand-name drugs: results of a national survey of physicians.
    Campbell EG; Pham-Kanter G; Vogeli C; Iezzoni LI
    JAMA Intern Med; 2013 Feb; 173(3):237-9. PubMed ID: 23303297
    [No Abstract]   [Full Text] [Related]  

  • 37. The impact of physician attitudes and beliefs on treatment decisions: lipid therapy in high-risk patients.
    Foley KA; Denke MA; Kamal-Bahl S; Simpson R; Berra K; Sajjan S; Alexander CM
    Med Care; 2006 May; 44(5):421-8. PubMed ID: 16641660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prescription of teratogenic medications in United States ambulatory practices.
    Schwarz EB; Maselli J; Norton M; Gonzales R
    Am J Med; 2005 Nov; 118(11):1240-9. PubMed ID: 16271908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Social deprivation and statin prescribing: a cross-sectional analysis using data from the new UK general practitioner 'Quality and Outcomes Framework'.
    Ashworth M; Lloyd D; Smith RS; Wagner A; Rowlands G
    J Public Health (Oxf); 2007 Mar; 29(1):40-7. PubMed ID: 17071815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changing physician prescribing patterns: evaluation of an educational strategy for acute diarrhea in Mexico City.
    Gutiérrez G; Guiscafré H; Bronfman M; Walsh J; Martínez H; Muñoz O
    Med Care; 1994 May; 32(5):436-46. PubMed ID: 8182972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.